[EN] SUBSTITUTED 3-PYRIDYL PYRROLES AND 3-PYRIDYL PYRAZOLES AS C17,20 LYASE INHIBITORS<br/>[FR] 3-PYRIDYL PYRROLES ET 3-PYRIDYL PYRAZOLES SUBSTITUES EN TANT QU'INHIBITEURS DE LA LYASE C17,20
申请人:BAYER AG
公开号:WO2003027101A1
公开(公告)日:2003-04-03
The invention provides novel substituted 3-pyridyl pyrroles and 3-pyridyl pyrazoles and pharmaceutical compositions thereof. The invention also provides methods of use of substituted 3-pyridyl pyrroles and 3-pyridyl pyrazoles and pharmaceutical compositions thereof as inhibitors of lyases, e.g., the 17α-hydroxylase-C17,20 enzyme. The invention further provides methods for the treatment of cancer in a subject, comprising administering a substituted 3-pyridyl pyrroles and 3-pyridyl pyrazoles or a pharmaceutical composition comprising a substituted 3-pyridyl pyrroles and 3-pyridyl pyrazoles to a subject. The cancer can be, e.g., prostate cancer or breast cancer.